Author - Ilar

Statement on the use of NSAIDs in the treatment of COVID-19

ILAR Latin American Industry for Responsible Self-Care advises the population in Latin America, who have questions about pain and fever management during the COVID-19 pandemic, to trust the recommendations of health professionals, the communiqués of health portals administered by the National Government, as well as the indications of approved for over-the-counter medications. Recent speculation about a link between the...

ILAR participated in the Health Forum and 26th Pharmaceutical Forum of the ANDI, Colombia, held in Cartagena.

This Forum is the space that summons all health actors around the topics of greatest interest and topicality of the system . One of the sessions of greatest interest was the panel on the Self-Care Policy as a Strategy for the Sustainability of the Health System. Formed by Iván Darío González Vice Minister of Health, Mauricio Santamaría, Former Minister...

Brazil establishes automatic conciliation of drug registration that has been authorized by the health authorities of other countries

The bill of law 3847/2019 created by Congress General Paternell (PSL) offers permission to the approval of medication, which has been already authorized by the sanitary authorities of other countries. The project defines that the health agencies of the USA, Japan, Canada and the European countries are reconnected in the reliance process for approval of the sanitary registration of medicines....

Proposal for the use of the Braille System in packaging of food products and medicines

The law project 63-2018 created by Maria del Rosario Guerra (Democratic Center) propose the adoption of the Braille System in food, medical and tourist services packages, as well as in public places. The text states that any company that markets the public food and medicines, both national and imported, should include informational labels, of the Braille system, with the intention...

Health Commission Advisors will discuss Advertising Regulations for Over-The-Counter Medicines in Argentina

The advisers of the Commission of Systems, Media and Freedom of Expression from the Argentine Senate, chaired by Alfredo Luenzo (Somos Todos - opposition) debated a bill on the advertising of OTC medicines, an initiative presented by the opposition senator Daniel Lovera (La Pampa). The commission advisors began studying the text in August. On that occasion, they agreed with the...

COFEPRIS announces the revocation of advertising criteria and guidelines

In accordance with article 4 of the Federal Law of Administrative Procedure and article 71 of the General Law of Regulatory Improvement, the guidelines and criteria regarding: attention for the procedure of advertising of non-prescription medicines (OTCs), homeopathic and herbal remedies, the promotion of healthy habits, advertising permits for alcoholic beverages, and administrative simplification for digital advertising procedures, show...

Medicines II Bill

Currently, a set of amendments to the Health Code known as the Medicnes II Bill by the Executive, is in legislative process. While there are positive proposals that tend to reduce the price of medicines, such as allowing the sale of OTC medicines in commercial establishments, there are also other very harmful ones, such as establishing price fixations, banning of...

ANVISA opens public consultation to update the list of over-the-counter medications

On September, ANVISA published in the Journal of the Union the public consultation to update the list of over-the-counter medicines. Interested in participating may do so from October 2, until November 18. The regulations put into consultation define the list of medicines classified by Anvisa as exempt from prescription (MIPs for its acronym in Portuguese), for synthetic and biological...

ILAR OTC Group Event – CDMX 2019

On July 24th and 25th, ILAR's OTC Group Meeting took place in Mexico City during the International Self-Care Week. Representatives of the Regulatory Agencies and National Association from Argentina, Brazil, Colombia and Mexico as well as experts and the private sector gathered to discuss relevant aspects in terms of regulatory harmonization, research and tools for collecting factual information and trends...

ILAR in Washington DC at the 57th Meeting of the Directing Council of the Pan American Health Organization (PAHO)

ILAR’s Director General Juan Thompson attended the 57th meeting of the Directing Council of the Pan American Health Organization in Washington DC. From September 30th to October 4th, the event brought together Ministers of Health and other high-level delegates from the Americas to discuss health priorities and action plans. A new PAHO Strategic Plan 2020-2025 was launched during the meeting, which...